Financial results - 3S PHARMACOLOGICAL CONSULTATION & RES. SRL

Financial Summary - 3S Pharmacological Consultation & Res. Srl
Unique identification code: 18714681
Registration number: J2006008691400
Nace: 8622
Sales - Ron
1.387.487
Net Profit - Ron
22.301
Employees
24
Open Account
Company 3S Pharmacological Consultation & Res. Srl with Fiscal Code 18714681 recorded a turnover of 2024 of 1.387.487, with a net profit of 22.301 and having an average number of employees of 24. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - 3S Pharmacological Consultation & Res. Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 1.507.643 1.855.903 2.187.519 1.599.998 1.361.266 926.170 975.332 1.634.936 1.278.039 1.387.487
Total Income - EUR 1.542.245 1.893.612 2.216.670 1.605.524 1.382.425 928.667 977.647 1.645.896 1.315.277 1.394.465
Total Expenses - EUR 1.753.928 2.151.559 2.435.184 1.765.778 1.549.516 986.761 1.234.605 1.482.487 1.312.754 1.358.798
Gross Profit/Loss - EUR -211.683 -257.946 -218.513 -160.253 -167.091 -58.094 -256.959 163.408 2.523 35.667
Net Profit/Loss - EUR -213.609 -270.388 -229.366 -168.298 -168.718 -61.127 -264.602 154.093 -8.125 22.301
Employees 20 23 21 23 23 22 21 0 26 24
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 9.2%, from 1.278.039 euro in the year 2023, to 1.387.487 euro in 2024. The Net Profit increased by 22.301 euro, from 0 euro in 2023, to 22.301 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - 3S Pharmacological Consultation & Res. Srl

Rating financiar

Financial Rating -
3S PHARMACOLOGICAL CONSULTATION...

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
3S Pharmacological Consultation...

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
3S Pharmacological Consultation...

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
3S Pharmacological Consultation...

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - 3S Pharmacological Consultation & Res. Srl - CUI 18714681

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 1.616.067 1.459.622 1.348.933 1.280.434 1.216.482 1.144.683 1.078.981 1.064.957 997.519 943.599
Current Assets 396.003 468.962 271.670 584.515 245.871 108.795 90.170 52.840 65.470 100.388
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 261.172 221.080 196.694 508.227 224.997 99.930 88.329 49.209 60.739 58.815
Cash 134.831 247.883 74.976 76.288 20.874 8.866 1.840 3.632 4.731 41.573
Shareholders Funds 811.493 394.534 -26.217 -320.046 -593.477 -678.172 -927.735 -851.228 -882.040 -858.887
Social Capital 1.125 49.886 49.042 48.142 1.054 1.034 1.011 1.014 1.011 1.005
Debts 645.117 1.534.050 807.947 784.532 830.236 966.844 825.629 805.987 1.741.168 1.911.164
Income in Advance 555.460 969.658 838.872 1.400.463 1.225.593 964.806 1.271.256 1.163.038 203.861 435
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 100.388 euro in 2024 which includes Inventories of 0 euro, Receivables of 58.815 euro and cash availability of 41.573 euro.
The company's Equity was valued at -858.887 euro, while total Liabilities amounted to 1.911.164 euro. Equity increased by 18.223 euro, from -882.040 euro in 2023, to -858.887 in 2024. The Debt Ratio was 181.5% in the year 2024.

Risk Reports Prices

Reviews - 3S Pharmacological Consultation & Res. Srl

Comments - 3S Pharmacological Consultation & Res. Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.